Kemal Malik
Board Member
Cartesian Therapeutics, Inc. (RNAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kemal Malik
Kemal Malik is recorded as Board Member at Cartesian Therapeutics, Inc. (RNAC). Cartesian Therapeutics, Inc. reported in an 8-K filed July 2, 2024 that Kemal Malik was appointed Class II director, effective July 1, 2024.
“On July 1, 2024, the Board of Directors (the "Board") of the Company appointed Kemal Malik, MBBS as a Class II director, and fixed the size of the Board at nine directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cartesian Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Carrie S. Cox Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.